Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy

In vitro and pre-clinical studies have suggested that addition of the diet-derived agent curcumin may provide a suitable adjunct to enhance efficacy of chemotherapy in models of colorectal cancer. However, the majority of evidence for this currently derives from established cell lines. Here, we util...

Descripción completa

Detalles Bibliográficos
Autores principales: James, Mark I., Iwuji, Chinenye, Irving, Glen, Karmokar, Ankur, Higgins, Jennifer A., Griffin-Teal, Nicola, Thomas, Anne, Greaves, Peter, Cai, Hong, Patel, Samita R., Morgan, Bruno, Dennison, Ashley, Metcalfe, Matthew, Garcea, Giuseppe, Lloyd, David M., Berry, David P., Steward, William P., Howells, Lynne M., Brown, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ireland 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510144/
https://www.ncbi.nlm.nih.gov/pubmed/25979230
http://dx.doi.org/10.1016/j.canlet.2015.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510144/
https://www.ncbi.nlm.nih.gov/pubmed/25979230
http://dx.doi.org/10.1016/j.canlet.2015.05.005

Ejemplares similares